Kazia Therapeutics Limited Skyrocketed
Wed, Nov 20, 2019 at 05:30 PM
Kazia Therapeutics Limited (KZIA:NASDAQ) soared today at $7.4, representing a gain of 105.6%. On Tue 19 Nov 19, KZIA:NASDAQ touched a New 2-Week High of $3.6. The stock appeared on our News Catalysts scanner on Wed 23 Oct 19 at 04:27 AM. From Wed 30 Oct 19, the stock recorded 57.14% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Cancer Genetics, Inc. (CGIX:NASDAQ), 131.25%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 105.56%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 67.59%
- Aravive, Inc. (ARAV:NASDAQ), 48.08%
- Surface Oncology, Inc. (SURF:NASDAQ), 38.19%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 33.05%
- Amira Nature Foods Ltd. (ANFI:NYSE), 29.89%
- Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ), 28.67%
- Zion Oil & Gas, Inc. (ZN:NASDAQ), 25.21%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 25.15%